[HTML][HTML] Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
L Gervaso, D Ciardiello, RA Oliveira… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) revolutionized the management of mismatch repair-
deficient (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal (GI) cancers. Based …
deficient (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal (GI) cancers. Based …